[关键词]
[摘要]
目的：比较577nm微脉冲激光与药物治疗中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy，CSC)的疗效。
方法：选择我院2012-01-01/09-31的CSC患者45例45眼为激光组，行577nm微脉冲激光治疗，并与药物组(40例40眼)的疗效比较。
结果：激光组于治疗后6wk全部治愈，比药物治疗组恢复时间更短，见效更快。
结论：577nm微脉冲激光治疗CSC是安全有效的，并可减少CSC的复发。
[Key word]
[Abstract]
AIM: To compare the efficacy of 577nm micro-pulse laser and drug in the treatment of central serous chorioretinopathy(CSC).
METHODS: Forty-five CSC cases(45 eyes), in our hospital from January 1, 2012 to September 31, 2012, were received 577nm micro-pulse laser in laser group. Forty cases(40 eyes)got drug in drug group. The efficacy of two groups was compared.
RESULTS: All eyes in laser group were cured at 6 weeks after treatment, which was shorter than that in drug group.
CONCLUSION: 577nm micro-pulse laser treatment for CSC is safe and effective, and can reduce the recurrence of CSC.
[中图分类号]
[基金项目]
